Kursprognose für X T L Biopharmaceuticals Ltd (XTLB)XTLBX T L Biopharmaceuticals Ltd

Alphio's XTLB stock price prediction model matches the current X T L Biopharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.54 (-0.71%). The 1-week path is $1.53 (-1.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

XTL Biopharmaceuticals Ltd is not a good buy right now due to its current price of $1.55, which is significantly below its 52-week high of $5.64 and reflects a staggering 58.91% decline over the past year. Additionally, the company's RSI is at 28.491, indicating it is oversold, but the lack of positive financial indicators such as a gross margin of 0.00% and a forward P/E of 0 raises serious concerns about its profitability and future growth potential. The main risk is the Nasdaq delisting notice, which could further depress the stock price if not resolved.

X T L Biopharmaceuticals Ltd (XTLB) last closed at $1.55, losing -9.36%. These facts feed the 1-day and 1-week XTLB price prediction above.